ArticleClinical, cosmetic and investigational dermatology2025
Influence of Immune Cells and Circulating Inflammatory Cytokines on Pathological Scars: A Mendelian Randomization Study.
Article in Clinical, cosmetic and investigational dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pathological scars are the products of abnormal repair during the wound healing process. Previous researches have demonstrated that immune cells and inflammatory cytokines are closely associated with pathological scars. However, the causality between immune cells, inflammatory cytokines and pathological scars remains unclear. Methods: After obtaining genome-wide association studies (GWAS) data on immune cells, cytokines, hypertrophic scars, and keloids, we selected appropriate single - nucleotide polymorphisms (SNPs) for Mendelian randomization (MR) analysis. The inverse-variance weighted (IVW) method was used as the main analytical method. Sensitivity analyses were conducted to evaluate reliability of research findings. Results: Our research results indicated that 10 immunophenotypes can increase risk of hypertrophic scars, 5 immunophenotypes can decrease risk of hypertrophic scars, 3 inflammatory cytokines can increase risk of hypertrophic scars, and 2 inflammatory cytokines can decrease risk of hypertrophic scars. Meanwhile, 5 immunophenotypes can increase risk of keloids, 4 immunophenotypes can decrease risk of keloids, 1 inflammatory cytokine can increase risk of keloids, and 1 inflammatory cytokine can decrease risk of keloids. Conclusion: This study reveals the roles of immune phenotypes and cytokines in the pathogenesis of pathological scars, and provides valuable references in research areas such as early identification and intervention treatment of pathological scars.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.